{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-200555","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.402824+00:00","generated_at":"2026-06-12T18:13:08.997653+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Guardant settles Illumina litigation, extends commercial partnership with three-year agreement","bullets":["Guardant and Illumina agreed to dismiss with prejudice the March 2022 Delaware lawsuit, including all IP allegations.","New three-year collaboration covers sharing of specimen samples for cancer research and a long-term purchase/supply commitment.","The agreement extends the companies' longstanding commercial relationship; no financial terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-200555","json":"https://secwatch.observer/filing/0001193125-23-200555.json","markdown":"https://secwatch.observer/filing/0001193125-23-200555.md","text":"https://secwatch.observer/filing/0001193125-23-200555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000119312523200555/0001193125-23-200555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000119312523200555/d542051d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T18:13:08.997653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}